Arguing against that scenario, it is notable that intralymphatic GAD65 with vitamin D supplementation slowed the loss of C-peptide production in new T1D patients carrying HLA DR3-DQ2, but not those negative for HLA DR3-DQ2 [5,6]. Here, GAD2 is linked to type 1 diabetes mellitus.